Vir Biotechnology
(NASDAQ) VIR
Vir Biotechnology Financials at a Glance
Market Cap
$1.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$65.50M
Net Income (TTM)
-$442.72M
EPS (TTM)
-$3.14
P/E Ratio
-3.20
Dividend
$0.00
Beta (Volatility)
1.33 (Average)
Dividend
$0.00
Beta (Volatility)
1.33 (Average)
Price
$10.02
Volume
1,569,881.454
Open
$9.97
Price
$10.02
Volume
1,569,881.454
Open
$9.97
Previous Close
$10.02
Daily Range
$9.74 - $10.18
52-Week Range
$4.16 - $11.66
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
1.33 (Average)
Price
$10.02
Volume
1,569,881.454
Open
$9.97
Previous Close
$10.02
Daily Range
$9.74 - $10.18
52-Week Range
$4.16 - $11.66
Estimated Earnings Date
Aug 5, 2026
VIR News
VIR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vir Biotechnology
Industry
Biotechnology
Sector
Health CareEmployees
367
CEO
Marianne de Backer, PhD, MBA
Website
www.vir.bioHeadquarters
San Francisco, CA 94158, US
VIR Financials
Key Financial Metrics (TTM)
Gross Margin
275.25%
Operating Margin
-704.87%
Net Income Margin
-675.96%
Return on Equity
-53.31%
Return on Capital
-49.15%
Return on Assets
-43.17%
Earnings Yield
-31.25%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
168.65M
Volume
1.57M
Avg. Volume
1.92M
Financials (TTM)
Gross Profit
$180.27M
Operating Income
-$461.65M
EBITDA
-$438.52M
Operating Cash Flow
-$446.05M
Capital Expenditure
$1.24M
Free Cash Flow
-$444.81M
Cash & ST Invst.
$472.36M
Total Debt
$95.58M
Vir Biotechnology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
-$29.00K
-101.0%
Gross Profit
-$2.84M
+97.5%
Gross Margin
97.93%
N/A
Market Cap
$1.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$4.15M
N/A
Employees
408
N/A
Net Income
-$125.70M
-3.9%
EBITDA
-$122.71M
+9.5%
Quarterly Fundamentals
Total Cash
$472.36M
-41.1%
Total Debt
$95.58M
-0.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$86.64M
-1.7%
Short Term Debt
$8.94M
+12.9%
Return on Assets
-43.17%
N/A
Return on Invested Capital
-48.49%
N/A
Free Cash Flow
-$132.78M
-66.5%
Operating Cash Flow
-$132.39M
-69.5%